The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Letters to the EditorFull Access

Ketamine and Memory Loss

In the article “Bipolar-Depression Improvement Follows Ketamine Infusion” in the September 17 issue, dissociation is described as a common side effect of ketamine. Actually, dissociation based on the loss of short-term memory has long been considered a major effect of ketamine. This function even led to the use of Sernyl, a ketamine, as an animal anesthetic. For a short time, there was also some experimentation with its use in pediatric surgery.

Instead of researchers' dismissing dissociation as an unrelated side effect of ketamine, it might be of interest to study the antidepressant effects of short-term memory loss. Such a study would be of special interest because of the possible link between the antidepressive effects of ECT and post-ECT memory loss.

In my book Multiple Realities in Clinical Practice, I have written about the effects of a ketamine, specifically Sernyl, on human subjects.

JOHN S. KAFKA, M.D. Bethesda, Md.